| Eiko Lifesciences Ltd | Industry : (Chemicals) | |
|---|---|---|
|
BSE Code : 540204 |
NSE Symbol : - |
P/E(TTM) : 22.75 |
|
ISIN Demat : INE666Q01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.26 |
|
Book Value(₹) : 42.22 |
Market Cap(₹Cr) : 70.55 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 9.57 | 9.20 | 7.45 | 7.09 | 6.91 | 7.74 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 9.57 | 9.20 | 7.45 | 7.09 | 6.91 | 7.74 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.56 | 0.56 | 0.55 | 0.87 | 0.10 | 0.13 |
| Total Income | 10.13 | 9.76 | 8.01 | 7.96 | 7.02 | 7.87 |
| Total Expenditure | 8.70 | 8.48 | 6.93 | 6.58 | 6.46 | 7.39 |
| PBIDT | 1.43 | 1.29 | 1.07 | 1.38 | 0.56 | 0.48 |
| Interest | 0.04 | 0.07 | 0.02 | 0.04 | 0.02 | 0.04 |
| PBDT | 1.39 | 1.22 | 1.06 | 1.34 | 0.53 | 0.44 |
| Depreciation | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.16 |
| Tax | 0.27 | 0.23 | 0.20 | 0.26 | 0.07 | 0.05 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.03 |
| Reported Profit After Tax | 0.95 | 0.82 | 0.69 | 0.90 | 0.28 | 0.21 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.26 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.95 | 0.82 | 0.69 | 0.64 | 0.28 | 0.21 |
| EPS (Unit Curr.) | 0.69 | 0.60 | 0.50 | 0.69 | 0.24 | 0.16 |
| EPS (Adj) (Unit Curr.) | 0.69 | 0.60 | 0.50 | 0.69 | 0.24 | 0.16 |
| Calculated EPS (Unit Curr.) | 0.69 | 0.60 | 0.50 | 0.65 | 0.22 | 0.16 |
| Calculated EPS (Adj) (Unit Curr.) | 0.69 | 0.60 | 0.50 | 0.65 | 0.22 | 0.16 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.76 | 2.38 | 2.01 | 2.62 | 0.89 | 0.65 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.76 | 2.38 | 2.01 | 2.62 | 0.89 | 0.65 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.72 | 13.72 | 13.76 | 13.76 | 12.87 | 12.87 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 14.94 | 14.02 | 14.36 | 19.46 | 8.10 | 6.20 |
| PBDTM(%) | 14.52 | 13.26 | 14.23 | 18.90 | 7.67 | 5.68 |
| PATM(%) | 9.93 | 8.91 | 9.26 | 12.69 | 4.05 | 2.71 |